Profiling Inflammatory Cytokines in a Cohort Study of Egyptian Patients with COVID-19 Infection

Clinical Laboratory
|June 10, 2021
PubMed

Insights

Elevated inflammatory biomarkers like IL-6, CRP, ferritin, LDH, and D-dimer correlate with COVID-19 severity. These markers, along with older age, male gender, and chronic disease, are key risk factors for severe coronavirus disease 2019.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Biomarkers

Background:

  • The COVID-19 pandemic presents a global health crisis, exacerbated by cytokine storm syndrome.
  • Understanding risk factors and inflammatory responses is crucial for managing severe cases.

Purpose of the Study:

  • To evaluate inflammatory biomarkers in COVID-19 patients.
  • To identify risk factors associated with COVID-19 severity.

Main Methods:

  • A cross-sectional study involving 150 Egyptian COVID-19 patients.
  • Patients categorized by disease severity (mild, moderate, severe) based on clinical and CT findings.
  • Laboratory analysis of serum inflammatory biomarkers.

Main Results:

  • A significant negative correlation was observed between oxygen saturation and serum inflammatory markers.
  • Interleukin-6 (IL-6), C-reactive protein (CRP), ferritin, lactate dehydrogenase (LDH), and D-dimer showed significant correlations with severity.
  • These biomarkers can indicate the risk of severe COVID-19 infection.

Conclusions:

  • Risk factors for severe COVID-19 include older age, male gender, and pre-existing chronic conditions.
  • Elevated levels of CRP, LDH, ferritin, IL-6, and D-dimer are associated with increased COVID-19 severity.
  • These inflammatory markers are valuable for assessing the risk of severe infection.
Abstract